Dewpoint Therapeutics
PrivateLast Round
Series D
Sep 10, 2025
Total Funding Raised
$346.1M
Company Overview
Dewpoint Therapeutics is a biotechnology company that develops innovative healthcare technology to discover novel drugs for a wide range of diseases using an AI-powered platform and advanced imaging tools.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, ML Platforms, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Dewpoint Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Dewpoint Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Sep 10, 2025 | ||||
| Series C | Feb 3, 2022 | ||||
| Series B | Sep 29, 2020 | ||||
| Series A | Jan 30, 2019 |
Key People
Founding team and executive leadership
Dewpoint Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| EcoR1 Capital | Series C, Series B, Series A |
| SoftBank Investment Advisers | Series C |
| Maverick Ventures | Series C, Series A, Series B |
| Bencao Capital | Series C |
| Leaps by Bayer | Series C |
| Innovation Endeavors | Series B |
| ARCH Venture Partners | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 21, 2026
Presented preclinical data on Oral MYC condensate modulator at AACR 2026.
- Apr 21, 2026
Presented data at the AACR 2026 conference.
Dewpoint Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Dewpoint Therapeutics's valuation, stock price, and market status.
